Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Arterial Hypertension and Multiple Myeloma: Physiopathology and Cardiovascular Risk and 'Practical' Indications in Patients Receiving Carfilzomib.
Curr Hypertens Rev. 2019;15(1):47-53. doi: 10.2174/1573402114666180611110547.
Curr Hypertens Rev. 2019.
PMID: 29886833
Review.
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients.
Mingrone G, Astarita A, Airale L, Maffei I, Cesareo M, Crea T, Bruno G, Leone D, Avenatti E, Catarinella C, Salvini M, Cetani G, Gay F, Bringhen S, Veglio F, Vallelonga F, Milan A.
Mingrone G, et al. Among authors: maffei i.
Front Cardiovasc Med. 2021 Apr 21;8:645678. doi: 10.3389/fcvm.2021.645678. eCollection 2021.
Front Cardiovasc Med. 2021.
PMID: 33969010
Free PMC article.
Item in Clipboard
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy.
Bruno G, Bringhen S, Maffei I, Iannaccone A, Crea T, Ravera A, Astarita A, Vallelonga F, Salvini M, Gay F, Veglio F, Milan A.
Bruno G, et al. Among authors: maffei i.
Cancers (Basel). 2019 May 3;11(5):622. doi: 10.3390/cancers11050622.
Cancers (Basel). 2019.
PMID: 31058856
Free PMC article.
Item in Clipboard
Cite
Cite